Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Taraboletti

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Forum (Genoa, Italy)|September 30, 1999
Angiogenesis and angiogenesis inhibitors in cancerR Giavazzi, G Taraboletti
Current Opinion in Pharmacology|November 17, 2001
Antiangiogenic and antivascular therapy for cancerG Taraboletti, B Margosio
Critical Reviews in Oncology/Hematology|February 13, 2001
Preclinical development of metalloproteasis inhibitors in cancer therapyR Giavazzi, G Taraboletti
European Journal of Cancer (Oxford, England : 1990)|May 4, 2004
Modelling approaches for angiogenesisG Taraboletti, R Giavazzi
EXS|January 1, 1992
Thrombospondin modulates basic fibroblast growth factor activities on endothelial cellsG Taraboletti, D Belotti, R Giavazzi
Cancer Research|October 15, 1991
Laminin receptor complementary DNA-deduced synthetic peptide inhibits cancer cell attachment to endotheliumV Castronovo, G Taraboletti, M E Sobel
The Journal of Biological Chemistry|October 25, 1991
Functional domains of the 67-kDa laminin receptor precursorV Castronovo, G Taraboletti, M E Sobel
Invasion & Metastasis|January 1, 1986
Characterization of spontaneous metastases from autochthonous 3-methylcholanthrene-induced tumorsB Bottazzi, A Mantovani, G Taraboletti, et al.
The Journal of Cell Biology|November 1, 1987
Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domainsG Taraboletti, D D Roberts, L A Liotta
The Journal of Cell Biology|August 1, 1990
Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factorG Taraboletti, D Roberts, L A Liotta, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Forum (Genoa, Italy)|September 30, 1999
Angiogenesis and angiogenesis inhibitors in cancerR Giavazzi, G Taraboletti
Current Opinion in Pharmacology|November 17, 2001
Antiangiogenic and antivascular therapy for cancerG Taraboletti, B Margosio
Critical Reviews in Oncology/Hematology|February 13, 2001
Preclinical development of metalloproteasis inhibitors in cancer therapyR Giavazzi, G Taraboletti
European Journal of Cancer (Oxford, England : 1990)|May 4, 2004
Modelling approaches for angiogenesisG Taraboletti, R Giavazzi
EXS|January 1, 1992
Thrombospondin modulates basic fibroblast growth factor activities on endothelial cellsG Taraboletti, D Belotti, R Giavazzi
Cancer Research|October 15, 1991
Laminin receptor complementary DNA-deduced synthetic peptide inhibits cancer cell attachment to endotheliumV Castronovo, G Taraboletti, M E Sobel
The Journal of Biological Chemistry|October 25, 1991
Functional domains of the 67-kDa laminin receptor precursorV Castronovo, G Taraboletti, M E Sobel
Invasion & Metastasis|January 1, 1986
Characterization of spontaneous metastases from autochthonous 3-methylcholanthrene-induced tumorsB Bottazzi, A Mantovani, G Taraboletti, et al.
The Journal of Cell Biology|November 1, 1987
Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domainsG Taraboletti, D D Roberts, L A Liotta
The Journal of Cell Biology|August 1, 1990
Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factorG Taraboletti, D Roberts, L A Liotta, et al.
Pageof 6